Physician profile
Eric Mittelmann
NPI 1215291240
$40,881.12
in general payments reported to CMS, 2019-2025
6 companies · $21.38 in 2025
The $21.38 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.10 · 2020: $14.96 · 2021: $16.58 · 2022: $23K · 2023: $18K · 2024: $41.10 · 2025: $21.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $62.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,250.00 |
| Food and Beverage | $62.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Therapeutics, INC. | $40,750.00 | 2022-2023 | |
| Sunovion Pharmaceuticals INC. | $37.10 | 2019 | |
| Sk Life Science, INC. | $31.46 | 2021-2024 | |
| Vertical Pharmaceuticals, LLC | $26.22 | 2024 | Relexxii |
| Otsuka America Pharmaceutical, INC. | $21.38 | 2025 | Rexulti |
| Ucb, INC. | $14.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Mittelmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.